Neurotensin expressing neurons developed earlier than vasoactive intestinal polypeptide and vasopressin expressing neurons in the human suprachiasmatic nucleus

Neuroscience Letters

Volumn 335, Issue 3, 2003, Pages 175-178

  Xu, Hao ^a   Hu, Xiang You ^a,b   Wu, Lei ^b   Zhou, Jiang Ning ^a,b  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b First Affiliated Hosp of A M U   (China)

Author keywords

Development; Human; Immunocytochemistry; Neuropeptide Y; Neurotensin; Suprachiasmatic nucleus; Vasoactive intestinal polypeptide; Vasopressin

Indexed keywords

NEUROTENSIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOPRESSIN;

ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; FETUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MORPHOMETRICS; NERVE CELL; PREGNANCY; PRIORITY JOURNAL; SUPRACHIASMATIC NUCLEUS;

FEMALE; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROPEPTIDE Y; NEUROTENSIN; SUPRACHIASMATIC NUCLEUS; TIME FACTORS; VASOACTIVE INTESTINAL PEPTIDE; VASOPRESSINS;

EID: 0037413658     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01184-9     Document Type: Article

References (15)

1. Abrahamson E.E., Moore R.Y. Suprachiasmatic nucleus in the mouse: retinal innervation, intrinsic organization and efferent projections. Brain Res. 916:2001;172-191.
2. Buijs R.M., Pool C.W., vanHeerikhuize J.J., Sluiter A.A., van der Sluis P.J., Ramkema M., van der Woude T.P., van der Beek E. Antibodies to small transmitter molecules and peptides: production and application of antibodies to dopamine, serotonin, GABA, vasopressin, vasoactive intestinal polypeptide, neuropeptide-Y, somatostatin and substance P. Biomed. Res. 10:1989;213-221.
3. Coogan A.N., Rawlings N., Luckman S.M., Piggins H.D. Effects of neurotensin on discharge rates of rat suprachiasmatic nucleus neurons in vitro. Neuroscience. 103:2001;663-672.
4. Cruz-Orive L.M. Distribution-free estimation of sphere size distributions from slabs showing overprojection and truncation, with a review of previous methods. J. Microsc. 131:1983;265-290.
5. Goncharuk V.D., van Heerikhuize J., Dai J.P., Swaab D.F., Buijs R.M. Neuropeptide changes in the suprachiasmatic nucleus in primary hypertension indicate functional impairment of the biological clock. J. Comp. Neurol. 431:2001;320-330.
6. Mai J.K., Triepel J., Metz J. Neurotensin in the human brain. Neuroscience. 22:1987;499-524.
7. Miller J.D. On the nature of the circadian clock in mammals. Am. J. Physiol. 264:1993;R821-R832.
8. Moore R.Y. The geniculohypothalamic tract in monkey and man. Brain Res. 486:1989;190-194.
9. Moore R.Y. The organization of the human circadian timing system. Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., Van Leeuwen F.W. The Human Hypothalamus in Health and Disease, Progress in Brain Research. 1992;101-118 Elsevier, Amsterdam.
10. Romijn H.J., van Uum J.F., Emmering J., Goncharuk V., Buijs R.M. Colocalization of VIP with AVP in neurons of the human paraventricular, supraoptic and suprachiasmatic nucleus. Brain Res. 832:1999;47-53.
11. Reppert S.M., Schwartz W.J. Maternal coordination of the fetal biological clock in utero. Science. 220:1983;969-971.
12. Reppert S.M., Henshaw D., Schwartz W.J., Weaver D.R. The circadian-gated timing of birth in rats: disruption by maternal SCN lesions or by removal of the fetal brain. Brain Res. 403:1987;398-402.
13. Seron-Ferre M., Torres-Farfan C., Forcelledo M.L., Valenzuela G.J. The development of circadian rhythms in the fetus and neonate. Semin. Perinatol. 25:2001;363-370.
14. Swaab D.F., Hofman M.A., Honnebier M.B.O.M. Development of vasopressin neurons in the human suprachiasmatic nucleus in relation to birth. Brain Res. Dev. Brain Res. 52:1990;289-293.
15. Swaab D.F., Zhou J.N., Ehlhart T., Hofman M.A. Development of vasoactive intestinal polypeptide neurons in the human suprachiasmatic nucleus in relation to birth and sex. Brain Res. Dev. Brain Res. 79:1994;249-259.